Searle's Calan
Executive Summary
Firm's verapamil HCl 40 and 160 mg tablets were incorrectly listed in May's report of NDA approvals as receiving an approvable letter as an original NDA ("The Pink Sheet" June 29, p. 9). Calan received an approvable letter as a supplement for the new dosages on May 19.